1. Distribution and persistence of technetium‐99 hexamethyl propylene amine oxime‐labelled bone marrow‐derived mesenchymal stem cells in experimentally induced tendon lesions after intratendinous injection and regional perfusion of the equine distal limb. (9th April 2013) Authors: Sole, A.; Spriet, M.; Padgett, K. A.; Vaughan, B.; Galuppo, L. D.; Borjesson, D. L.; Wisner, E. R.; Vidal, M. A. Journal: Equine veterinary journal Issue: Volume 45:Number 6(2013:Nov.) Page Start: 726 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Serial haemostatic monitoring of dogs with multicentric lymphoma. (25th May 2013) Authors: Kol, A.; Marks, S. L.; Skorupski, K. A.; Kass, P. H.; Guerrero, T.; Gosselin, R. C.; Borjesson, D. L. Journal: Veterinary and comparative oncology Issue: Volume 13:Number 3(2015:Sep.) Page Start: 255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The effects of therapeutic concentrations of gentamicin, amikacin and hyaluronic acid on cultured bone marrow‐derived equine mesenchymal stem cells. (28th February 2013) Authors: Bohannon, L. K.; Owens, S. D.; Walker, N. J.; Carrade, D. D.; Galuppo, L. D.; Borjesson, D. L. Journal: Equine veterinary journal Issue: Volume 45:Number 6(2013:Nov.) Page Start: 732 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗